Purtilo D T, Linder J, Volsky D J
Clin Lab Med. 1986 Mar;6(1):3-26.
The epidemiology, clinical and pathologic manifestations, identification of groups at high risk, results of laboratory analyses, and description of the modes of transmission of the putative etiologic agent HTLV-III/LAV have been summarized. Mechanisms of induction of T-cellular immunodeficiency have been described, including the role of HTLV-III/LAV, and possible roles of CMV and EBV as cofactors have been presented. Prospects for preventing and treating AIDS have been succinctly summarized.
已对人类嗜T淋巴细胞病毒III型/淋巴腺病相关病毒(HTLV-III/LAV)这一假定病原体的流行病学、临床和病理表现、高危人群的识别、实验室分析结果以及传播方式进行了总结。已描述了T细胞免疫缺陷的诱导机制,包括HTLV-III/LAV的作用,并介绍了巨细胞病毒(CMV)和EB病毒(EBV)作为辅助因子的可能作用。还简要总结了预防和治疗艾滋病的前景。